Suppr超能文献

移植后淋巴细胞增生性疾病的联合放疗与化疗

Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder.

作者信息

Tsai D E, Stadtmauer E A, Canaday D J, Vaughn D J

机构信息

Hematology-Oncology Division, University of Pennsylvania Medical Center, Philadelphia 19104, USA.

出版信息

Med Oncol. 1998 Dec;15(4):279-81. doi: 10.1007/BF02787213.

Abstract

The optimal treatment for posttransplant lymphoproliferative disorder which has progressed despite a reduction in immunosuppression has not been defined. We report on two patients with stage I posttransplant lymphoproliferative disorder who developed progressive disease despite a reduction in the level of immunosuppression. Both patients were treated with combined short course CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy followed by involved-field radiation therapy. In both patients, a rapid response was obtained followed by complete remission. Combined modality therapy can be utilized successfully in progressive limited stage posttransplant lymphoproliferative disorder.

摘要

尽管免疫抑制水平降低,但仍进展的移植后淋巴细胞增生性疾病的最佳治疗方法尚未明确。我们报告了两名I期移植后淋巴细胞增生性疾病患者,尽管免疫抑制水平降低,但仍出现疾病进展。两名患者均接受了短疗程CHOP(环磷酰胺、阿霉素、长春新碱和泼尼松)联合化疗,随后进行受累野放射治疗。两名患者均迅速出现反应,随后完全缓解。联合治疗模式可成功用于进展性局限期移植后淋巴细胞增生性疾病。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验